ArticleDiabetes, obesity & metabolism2026
Smartphone-Based Automated Basal Insulin Titration During Ramadan Fasting: Data From Adults With Type 2 Diabetes in Saudi Arabia.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Smartphone-Based Automated Basal Insulin Titration During Ramadan Fasting: Data From Adults With Type 2 Diabetes in Saudi Arabia.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMany people with type 2 diabetes (PWT2D) using insulin are advised not to fast during Ramadan because of dysglycemia risk. Here, we examined the efficacy and safety of using a smartphone application to titrate basal insulin doses to fasting blood glucose (FBG) target 70-130 mg/dL in PWT2D who practiced Ramadan fasting.
methodsWe retrospectively analysed data from 106 PWT2D using basal insulin and My Dose Coach (MDC) who fasted during Ramadan 2022-2024 and had FBG data pre-, during, and after Ramadan. Per standard of care, those with pre-Ramadan FBG < 130 mg/dL had basal insulin doses reduced by 20% (Reduced Basal 'RB' Group). Those with pre-Ramadan FBG ≥ 130 mg/dL continued usual doses (Usual Basal 'UB' Group). During Ramadan, MDC guided basal insulin titration based on pre-sunset FBG.
resultsAverage FBG levels in the RB and UB groups were: pre-Ramadan (120 vs. 145 mg/dL, p < 0.01), week-1 (129 vs. 139 mg/dL, p = 0.14), week-2 (131 vs. 141 mg/dL, p = 0.13), week-3 (130 vs. 138 mg/dL, p = 0.07), week-4 (129 vs. 138 mg/dL, p = 0.11), and post-Ramadan (126 and 138 mg/dL, p = 0.03). In the RB group, the MDC app increased the average basal insulin dose from 29 units in Ramadan Week 1 to 33 units by Week 4; similarly, in the UB group, the mean dose increased from 34 to 38 units. The proportion of PWT2D with FBG 70-130 mg/dL was maintained throughout Ramadan in both groups with no documented FBG < 70 mg/dL.
conclusionUse of smartphone-based automated basal insulin titration during Ramadan fasting is effective in maintaining FBG levels within target in PWT2D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.